Case report | Open | Open Peer Review | Published:
Late-onset leukoencephalopathy with cerebral calcifications and cysts: case report and review of the literature
BMC Neurologyvolume 16, Article number: 19 (2016)
Leukoencephalopathy with calcifications and cysts (LCC or Labrune disease) is a relatively recently defined and exceptionally rare disease in which parenchymal cysts and calcifications within a widespread leukoencephalopathy can cause a broad spectrum of neurological symptoms. The cause of the disease is unknown. Manifestation is usually in childhood or adolescence, while onset in adulthood has been described in 19 cases.
Here we report a case of an adult-onset LCC of a Caucasian woman who became symptomatic at age 70 as confirmed by typical neuroimaging and neuropathological findings. After resection of left mesioparietal space-occupying cystic brain tissue the patient has so far remained clinically stable during one year of follow-up with a continuous treatment with glucocorticosteroids.
To our knowledge this report of a patient who became symptomatic at age 70 represents the oldest age-at-onset case of LCC described so far.
Leukoencephalopathy with cerebral calcifications and cysts (LCC) is a leukoencephalopathy syndrome defined some 20 years ago . Its name contains the triad of its disease-defining features. Having been first described in 1996 by Labrune et al. , the disease which sometimes bears his name, has been reported in fewer than 50 cases in the literature as of 2014 [2, 3]. Disease onset takes place in childhood-adolescence as well as in adulthood; while the course of the disease has been described as more aggressive in childhood, the main findings apparently are independent of age. Histopathology reveals ectasia of small vessels, calcification of the parenchyma as well as gliosis. Occurrence of “Rosenthal-fibers” – hematoxylin and eosin stain-positive aggregates of intermediate filaments – is regarded as a particular feature. Given its very specific characteristics, the diagnosis of this syndrome may be established through neuroimaging alone. In the largest series of 15, mainly childhood-onset, patients with LCC, computer tomography (CT) in all patients revealed parenchymal calcifications of varying degrees, typically involving the basal ganglia and the thalamus. Half of the patients also showed calcifications of the dentate nucleus and brainstem . In this same cohort, magnetic resonance imaging (MRI) showed periventricular and deep white matter leukoencephalopathy that was symmetrical in all but two patients. According to this report, cysts were found in all brain areas with no clear preference for any region. The clinical presentation of the patients thus depends on the extent and location of the brain lesions which often involve extended edema, and includes all types of central neurological findings. The disease may be fatal within several years after diagnosis, most often due to intracerebral bleeding, but may also remain stable for years. Regarding the etiology, a recent report on two sisters with histopathologically confirmed LCC indicates that this is a genetic and possibly autosomal recessive disorder . Here, we present another case of an adult-onset patient with histopathologically confirmed LCC, in which characteristic findings are described and set in relation to the available literature.
A 70-year-old right-handed woman had complained about dizziness and unsteadiness of gait for several months. She also reported moderate headaches which she had not had previously. Moreover, she experienced memory deficits as well as difficulty finding words. She also noted that while experienced in target shooting with a pistol, her accuracy had decreased significantly within this same period. Aside from arterial hypertension and a deep vein thrombosis that had occurred within the year prior to admission, there were no major co-morbidities. The family history for neurological disorders was reported as normal. However, the patient’s parents were deceased and the patient did not have siblings.
A first MRI-scan revealed extended brain edema of the left hemisphere including left parietal cystic lesions. A brain biopsy was performed and repeated several months later. Both brain specimens obtained contained spongiform tissue with microangiopathy and no signs of malignancy, but did not allow a firm diagnosis to be made. The patient was then admitted to our hospital. Upon examination we found an incomplete right-sided hemianopia and very discrete right-sided hemiparesis, including a reflex difference with more definite reflexes on the right side. Coordination was mildly impaired. Additionally, she demonstrated word-finding difficulties and signs of apraxia of the right hand. She had been on high-dose glucocorticosteroids initiated probably after her first MRI; in the meantime she had also received medication against arterial hypertonia and antiepileptic medication following a first epileptic seizure. A recurrent MRI confirmed the initial findings of mainly left hemispheric leukoencephalopathy and a left parietal cyst (Figs. 1 and 2).
After reviewing the results of the first two biopsies that had been performed while the patient was already taking glucocorticoids, we decided to discontinue the steroid treatment in order to improve the diagnostic accuracy with respect to the exclusion of a cerebral lymphoma. When the patient was re-admitted 4 weeks later, she reported a worsening of her symptoms, her foremost complaint being memory problems. Consistent with this, the patient only scored 10 of 30 possible points on the mini-mental-status-examination (MMST), while during the first admission her test performance had been 21 of 30 points. Radiologically, the left hemispheric brain edema had increased resulting in a more pronounced midline shift of the left hemisphere than had already been present in the first imaging (Fig. 3). CCT showed evidence of some intraparenchymal calcification, but none in the basal ganglia, thalamus or cerebellum.
A resection in the left mesioparietal region with an area of dense vascular anomalies was performed after 2 more weeks. Typical findings of the biopsies and resection are shown in Fig. 4. These showed blood vessels with hyaline degeneration, signs of micro-bleedings and perivascular loss of myelin. Even though the typical mineralizations and cysts were not detected within the tissue the findings in conjunction with the results of the MRIs were regarded as suggestive for a leukoencephalopathy with calcifications and cysts.
Symptoms did decrease postoperatively and after resumption of the corticosteroids. However, after 2 months corticosteroids were once more tapered off and the symptoms again became more aggravated. Medication was therefore re-established as a long-term treatment with glucocorticoids and continues to date. The MRI one year after the initial presentation at our institution did show a stable course regarding the leukoencephalopathy which had even rather mildly decreased. Nevertheless, a small increase in the size of the largest cyst in the left posterior quadrant could be observed, as well as slight bleeding in one of the smaller cysts anterior to it (Fig. 5). Unfortunately, in the most recent follow-up visit 6 months later, the patient, though is still under constant treatment with corticosteroids, showed marked clinical deterioration; she was only able to communicate due to a mildly fluctuating sensory aphasia and completely relied on her husband’s assistance. Despite this clinical progression the MRI did not show significant changes. Her anti-epileptic medication was increased but did not profoundly change the clinical patient’s presentation.
Medication-wise, upon prolonged treatment with corticosteroids in doses of 2–4 mg fludrocortisone, the patient not unexpectedly developed typical signs of Cushing-syndrome, including weight gain, skin fragility and superficial skin infections. While the patient initially had received anti-coagulation treatment with phenprocoumon due to a deep vein thrombosis, this was discontinued in view of the risk of intracerebral bleeding with this diagnosis.
Ophthalmological examination confirmed a normal fundoscopy. The CSF revealed a mild elevation in the total protein (721 mg/l), but no cells, normal lactate and no oligoclonal bands. Rheumaserology and serology of vasculitis-typical antibodies was unremarkable. Results of neurophysiological testing accorded well with the clinical symptoms and neuroimaging, and showed centrally increased latencies of the sensory-evoked potentials involving the left hemisphere, as well as a marked slowing of the EEG rhythms generated by the left hemisphere with left temporal epileptiform activity in the EEG. This patient additionally received several modalities of neuroimaging including regular MRIs, a fluor-deoxy-glucose positrone-emission-tomography (FDG-PET), a single-photon-emission-computer-tomography (SPECT) as well as an angiography. The cerebral angiography revealed an unspecific enhancement of vascular contrast with early venous drainage in the left parietal region resembling small shunts. There was otherwise no abnormality of the brain-feeding arteries and no sign of vasculitis. FDG-PET and SPECT showed concordantly more left than right parieto-occipital hypometabolism and hypoperfusion.
Review of the literature
Upon a search of the literature in the Medline database, we identified 19 more cases of adult-onset LCC, the data of which were available to us. One of these cases was published as part of a series of 15 mainly juvenile-onset LCC. However, the clinical data of that specific case were not fully accessible within that publication. We were therefore able to include this case in this review . In another case report, the diagnosis of LCC was established at age 42, but long-standing dystonia and spasticity since early childhood did not allow inclusion of this case into the adult-onset case series . Including our case, we found the following characteristics based on a total of now 20 published cases of 10 male and 10 female patients. Diagnostically, histopathology was available in 90 % (18/20) and CSF in 35 % (7/20) of the patients. Seizures were part of the recent or overall medical history in 40 % (8/20). Therapeutically, in 60 % (12/20) a neurosurgical resection was performed. The prescription of steroids was reported in 20 % (4/20) (Table 1).
We describe the case of a 71-year-old female diagnosed with LCC and an onset of symptoms later in life than any so far reported in the literature. While there exists a previous report of another 71-year-old female with the same diagnosis  in that case the onset of symptoms was 6 years prior to diagnosis. Our patient however presented with first symptoms only a few months before a final diagnosis of LCC was made; rendering her the oldest patient to manifest first clinical LCC symptoms described so far. Here, the leukoencephalopathy was mainly left hemispheric. This is unusual, even though asymmetric distribution of this finding has been described before and may represent an early stage or varying expression of the disease . In our case we observe typical cysts, these being a defining feature of the disease that have been reported in all previous cases. Also, the cysts showed dynamic changes in the course of the follow-up, which is also regarded as typical for LCC . However, in contrast to previous descriptions of LCC, we found mild but not typically localized calcifications in the CCT. Indeed, most of the available case reports describe a rather typical neuroimaging that often included bilateral and marked calcifications within the basal ganglia, thalamus and cerebellum. While this pattern of parenchymal calcification resembles the pattern seen in Fahr’s disease, the differential diagnosis for Fahr’s disease is not accompanied by any of the additional features of LCC. We may thus speculate that the extent of LCC calcification is variable, and that the pattern we observe is also consistent with LCC.
The natural course of LCC appears to vary widely. Ages of clinical onset ranging from the first year of life to 70 years of age (including our case) have been reported, with some cases taking a fatal course and others maintaining clinical stability for years. Especially with respect to adult cases, it is not clear when the changes in cerebral structural occur. In one case, a 69-year-old Caucasian women presented with confusion, ataxia and left-sided hemianopia that had developed over the preceding several months, and the typical triad of LCC was subsequently confirmed through neuroimaging. However, neuroimaging that had been performed after a concussion 14 years prior to manifestation of the above-mentioned symptoms had already revealed the presence of cerebral calcifications and leukoencephalopathy, despite the fact that the patient was reportedly asymptomatic at that time; she thus underwent no follow-up . In another case report, brain images made 6 years before the patient’s main presentation and likely clinical manifestation were available and showed the same leukoencephalopathy as well as calcifications as the later brain images. However, the cysts that had likely induced the new symptoms had not been present on initial imaging . It therefore appears likely that − at least regarding adult-onset patients − there may be a long latency between structural and clinical manifestation of the disease. On the other hand, the formation of cysts apparently represents a more dynamic part of the disease with particular relevance for the clinical manifestation.
The etiology of the LCC is, as previously mentioned, unknown. A recently reported co-occurrence of LCC in two siblings strengthens the assumption that this is a genetically determined disease. Also a mutation of a gene encoding the cysteine protease inhibitor cystatin C (CST3) has been discussed as possibly relevant for the disease .
The pathogenesis of LCC apparently affects the structure and function of blood vessels, resulting in microangiopathy. It has been hypothesized that tissue hypoxia secondary to microangiopathy may then be responsible for the development of calcifications and cysts. Additionally, pathologic myelination may be responsible for the leukoencephalopathy. Especially, glial process thickenings similar to the Rosenthal fibers that are typical of LCC have been observed in Alexander’s disease, a demyelinating leukodystrophy associated with mutations in the glial fibrillary acidic protein (GFAP) . However, the white matter changes seen on the MRIs of patients with LCC apparently do not represent demyelination, but are more likely secondary to brain edema, which would fit well with the increase and decrease in leukoencephalopathy observed with the respective inactive or active glucocorticoid treatment in our case. Moreover, previous clinical case reports have noted differences between the extensive MRI abnormalities with vast subcortical hyperintensities in the T2-weighted sequences resembling patterns seen in leukodystrophies and the comparably more benign clinical phenotype which may be regarded as an indicator of a MRI-signal abnormality of less severe significance than would be the case with widespread demyelination.
The most effective therapeutic approach would likely involve a combination of corticosteroid therapy and surgical procedures, depending on the extent of the mass lesion. As always, chronic corticosteroid treatment should be minimized to the smallest dosage capable of maintaining a therapeutic effect. Interestingly, in two case reports it is mentioned that patients who had previously suffered from frequent headaches improved with steroid treatment [8, 9]. This may or may not indicate that these steroid-responsive headaches are symptomatically associated with the structural brain anomalies of LCC. Additionally, anticoagulants should be avoided in patients with LCC since histopathology indicates abnormal microvasculature. Indeed, several case studies describe the occurrence of spontaneous intracranial bleeding, and one report mentions a fatal intracranial hemorrhage that occurred most likely as a side-effect of treatment with an oral anticoagulant for deep vein thrombosis . Regarding invasive treatment, in most cases surgical procedures were usually performed to relieve the effect of the space-occupying cysts or lesions that often occur in LCC . Cystic lesions especially in areas that are accessible to neurosurgery may be resected. Also, in less accessible areas fenestration and shunting have been described as therapeutic alternatives .
Regarding differential diagnoses, Coats plus syndrome has been identified as a syndrome closely related to LCC; it has been hypothesized that both syndromes may represent variants of a single entity. Although both syndromes feature leukoencephalopathy with calcifications and cysts, what distinguishes Coats plus syndrome from LCC is that the former also manifests with prominent retinal vascular changes and osteopenia. Since these features as well as other systemic signs are absent in LCC, it is currently classified as purely a brain disease. Also, Coats plus syndrome has recently been associated with mutations in the CTC1 gene that is related to telomeric function [11, 12]. The lack of a mutation in the CTC1-gene in cases of LCC and its manifestation only in the central nervous system are currently regarded as the main features distinguishing Coats plus syndrome from LCC.
While onset of LCC most often is in childhood this disease can present late in life.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
leukodystrophy with calcifications and cysts
mangetic resonance imaging
Labrune P, Lacroix C, Goutieres F, de Laveaucoupet J, Chevalier P, Zerah M, et al. Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy. Neurology. 1996;46:1297–301.
Karlinger K, Tárnoki ÁD, Tárnoki DL, Polvi A, Lehesjoki AE, Kelemen A, et al. Leukoencephalopathy, cerebral calcifications and cysts: a family study. J Neurol. 2014;261:1911–6.
Livingston JH, Mayer J, Jenkinson E, Kasher P, Stivaros S, Berger A, et al. Leukoencephalopathy with calcifications and cysts: a purely neurological disorder distinct from coats plus. Neuropediatrics. 2014;45(3):175–82.
Ogles RL, Joshi CL, Miller DC, Litofsky NS, Travis MD. Leukoencephalopathy, cerebral calcifications, and cysts in two sisters. Pediatr Neurol. 2014;51:576–9.
Osman NI, Lorincz MT, Hulsing KL, Gebarski SS. Leukoencephalopathy, cerebral calcifications, and cysts: case report. Clin Neurol Neurosurg. 2012;114(6):806–9.
Banks GP, Weiss SA, Pisapia D, Willey JZ. A case of late-onset leukoencephalopathy, calcifications, and cysts presenting with intracerebral hemorrhage resembling a neoplasm. Cerebrovasc Dis. 2013;35(4):396–7.
Coeytaux A, Lobrinus JA, Horvath J, Kurian M, Vargas MI. Late onset of leucoencephalopathy with cerebral calcifications and cysts. J Neuroradiol. 2011;38:319–20.
Corboy JR, Gault J, Kleinschmidt-DeMasters BK. An adult case of leukoencephalopathy with intracranial calcifications and cysts. Neurology. 2006;67:1890–2.
Kaffenberger T, Valko PO, von Meyenburg J, Baráth K, Hewer E, Heppner FL, et al. A case of late onset leukoencephalopathy with cerebral calcifications and cysts in a 59-year-old woman. Eur J Neurol. 2009;16:278–81.
Berry-Candelario J, Kasper E, Eskandar E, Chen CC. Neurosurgical management of leukoencephalopathy, cerebral calcifications, and cysts: a case report and review of literature. Surg Neurol Int. 2011;2:160.
Anderson BH, Kasher PR, Mayer J, Szynkiewicz M, Jenkinson EM, Bhaskar SS, et al. Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet. 2012;44:338–42.
Polvi A, Linnankivi T, Kivela T, Herva R, Keating JP, Makitie O, et al. Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts. Am J Hum Genet. 2012;90:540–9.
Wang Y, Cheng G, Dong C, Zhang J, Meng Y. Adult-onset leukoencephalopathy, brain calcifications and cysts: a case report. J Med Case Rep. 2013;7:151.
Sener U, Zorlu Y, Men S, Bayol U, Zanapalioglu U. Leukoencephalopathy, cerebral calcifications, and cysts. AJNR Am J Neuroradiol. 2006;27:200–3.
Daglioglu E, Ergungor F, Hatipoglu HG, Okay O, Dalgic A, Orhan G, et al. Cerebral leukoencephalopathy with calcifications and cysts operated for signs of increased intracranial pressure: case report. Surg Neurol. 2009;72:177–81.
Marelli C, Savoiardo M, Fini N, Bartolomei I, Marliani AF, De Gonda F, et al. Late presentation of leucoencephalopathy with calcifications and cysts: report of two cases. J Neurol Neurosurg Psychiatry. 2008;79(11):1303–4.
Wargon I, Lacour MC, Adams D, Denier C. A small deep infarct revealing leukoencephalopathy, calcifications and cysts in an adult patient. J Neurol Neurosurg Psychiatry. 2008;79(2):224–5.
Bertotti MM, Linhares MN, Ferreira R, Santos DS, Athayde Jr AT, Mussi AC, et al. Leukoencephalopathy, cerebral calcifications, and cysts: entity that can mimic a neoplasm. Arq Neuropsiquiatr. 2011;69:717–22.
Pessoa AL, Monteiro Ado V, Queiroz RF, Malveira GL, Kok F. Leukoencephalopathy with cerebral calcifications and cyst: Labrune syndrome. Arq Neuropsiquiatr. 2012;70(3):230–1.
Gulati A, Singh P, Ramanathan S, Khandelwal N. A case of leukoencephalopathy, cerebral calcifications and cysts. Ann Indian Acad Neurol. 2011;14:310–2.
Kleinschmidt-Demasters BK, Cummings TJ, Hulette CM, Morgenlander JC, Corboy JR. Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorder. J Neuropathol Exp Neurol. 2009;68:432–9.
Ummer K, Salam KA, Noone ML, Pradeep Kumar VG, Mampilly N, Sivakumar S. Leukoencephalopathy with intracranial calcifications and cysts in an adult: case report and review of literature. Ann Indian Acad Neurol. 2010;13:299–301.
The authors declare that they have no competing interests.
CS examined, diagnosed, treated the patient and wrote the manuscript. AM performed the magnetic resonance imaging of the patient and reviewed the manuscript. ChS and SP performed histological analysis, diagnosed the patient and reviewed the manuscript. All authors read and approved the final manuscript.